title: Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome.
authors.forename: L
authors.initials: L
authors.lastname: Sokol
authors.forename: L
authors.initials: L
authors.lastname: Cripe
authors.forename: H
authors.initials: H
authors.lastname: Kantarjian
authors.forename: M A
authors.initials: MA
authors.lastname: Sekeres
authors.forename: S
authors.initials: S
authors.lastname: Parmar
authors.forename: P
authors.initials: P
authors.lastname: Greenberg
authors.forename: S L
authors.initials: SL
authors.lastname: Goldberg
authors.forename: V
authors.initials: V
authors.lastname: Bhushan
authors.forename: J
authors.initials: J
authors.lastname: Shammo
authors.forename: R
authors.initials: R
authors.lastname: Hohl
authors.forename: A
authors.initials: A
authors.lastname: Verma
authors.forename: G
authors.initials: G
authors.lastname: Garcia-Manero
authors.forename: Y-P
authors.initials: YP
authors.lastname: Li
authors.forename: A
authors.initials: A
authors.lastname: Lowe
authors.forename: J
authors.initials: J
authors.lastname: Zhu
authors.forename: A F
authors.initials: AF
authors.lastname: List
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D048308:Mitogen-Activated Protein Kinase 14 / Q000037:antagonists & inhibitors*; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D007211:Indoles; D047428:Protein Kinase Inhibitors; C499748:SCIO-469; D048308:Mitogen-Activated Protein Kinase 14